InvestorsHub Logo
Followers 0
Posts 387
Boards Moderated 0
Alias Born 06/16/2005

Re: bocxman post# 4533

Monday, 07/17/2006 3:25:29 PM

Monday, July 17, 2006 3:25:29 PM

Post# of 30387
Boxman,

Is this the kammerman you were talking about? If so, I view it as very positive.


June 17, 2006

SECTION: EXPANDED REPORTING; Pg. 84

LENGTH: 246 words

HEADLINE: COWEN AND COMPANY, LLC;
Cowen and Company adds medical technology sector analyst to equity research department

BODY:


Cowen and Company announced that Eli Kammerman has joined the firm as a Senior Analyst covering the Medical Technology sector.

Kammerman joins Cowen and Company from Cathay Financial in New York where he was a Medical Products Analyst. His prior experience includes eleven years in the health care industry, including Pharmacia Diagnostics, Genex Corporation and Novartis Pharmaceuticals, and ten years at Wall Street firms, including Merrill Lynch, Salomon Brothers and, most recently, Cathay Financial.

Kammerman earned a BA from Boston University and studied technology management at the graduate school of the University of Maryland. He will be based in New York and report directly to Barry Tarasoff, Cowen and Company's director of research.

"Eli's addition to Cowen and Company will extend our areas of coverage into several medical technology categories. Given his extensive experience in the health care industry, combined with his strong financial background, we are proud to add such a highly-respected analyst to our research team," said Barry Tarasoff.

Cowen and Company's Equity Research division has over 30 senior analysts covering approximately 500 companies in healthcare, technology, aerospace and defense, media and telecommunications and consumer sectors.

This article was prepared by Healthcare Mergers, Acquisitions & Ventures Week editors from staff and other reports. Copyright 2006, Healthcare Mergers, Acquisitions & Ventures Week via IncRx.com.

LOAD-DATE: June 9, 2006






Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.